Welcome to the April A to Z Blogging Challenge! Every year, bloggers from around the world commit to posting every day in April (except Sundays), working through the alphabet one letter at a time. This year, I’m visiting twenty-six fictional alternate Earths — worlds that diverged from our own at some crucial moment and became something wonderfully, unsettlingly different. Think of it like the TV show Sliders, which followed a group of travelers “sliding” between parallel dimensions, never quite knowing what version of Earth they’d land on next. Each day, we visit a new one. Today: M.

The Pill That Started Everything

In 1957, on an Earth that otherwise looks almost exactly like ours, a Swiss pharmaceutical researcher named Dr. Eliane Mettler was working on a compound intended to treat severe depression. The goal was modest by later standards — blunt the emotional edges of traumatic memory enough that patients could function, hold jobs, stop waking up screaming. The compound, internally designated RX-Mnemis, worked better than expected and in ways nobody had anticipated. It did not simply dull the emotional charge attached to a memory. Under certain conditions, administered at a specific concentration during a targeted period of REM sleep, it appeared to make traumatic memories transferable — loosened, somehow, from the specific neural architecture that had housed them, and capable of being extracted, stabilized in a chemical medium, and reintroduced into a different brain.

Mettler’s notes from this period are, on Memory Market Earth, what Newton’s Principia is on ours. Studied. Debated. Quoted at dinner parties by people who have never read them.

The first successful transfer happened in 1961. A veteran of the Korean War — a man whose name the official histories record as Patient 7, because the ethics review boards of the time were not yet thinking about legacy — had his most debilitating combat memories extracted over the course of six weeks and deposited into an inert chemical suspension. He reported feeling, afterward, a strange lightness. He said it was like a room that had been cluttered for years had been emptied. He did not say, in those early sessions, that the room felt too large now, or that he sometimes stood in the kitchen not knowing what he was doing there, or that his wife had begun looking at him the way you look at someone you are trying to recognize. Those things came later, in the follow-up notes that the pharmaceutical company that acquired Mettler’s research in 1963 chose not to publish.

The black market arrived before the regulation did, which is how these things tend to go.

The Years Nobody Talks About

By the mid-1970s, memory extraction and transfer had moved well beyond Swiss research hospitals. The technology had been replicated, simplified, and miniaturized by people whose interest in the ethics review process was limited. In the back rooms of certain cities — Amsterdam, Bangkok, Chicago’s south side, a particular stretch of São Paulo that the guidebooks did not include — you could, if you knew the right people and had the right amount of cash, purchase experiences you had never lived.

The early market was crude and dangerous. The extraction process, done without proper medical supervision, caused significant neurological damage in a meaningful percentage of cases. The memories themselves were unstable — contaminated with fragments of other sessions, misrouted, sometimes arriving with emotional valences wildly mismatched to their content, which produced in their recipients a particular kind of psychological distress that the illicit clinics were not equipped to treat. There were deaths. There were people who came out of underground transfer sessions unable to reliably distinguish their own memories from purchased ones, which is a condition that sounds almost abstractly interesting until you consider what it actually means to live inside it.

None of this slowed the market. It accelerated it.

What people were buying, in those early years, was not primarily courage or skill or the pleasant memories of other people’s vacations, though all of those existed. What they were buying, overwhelmingly, was relief. The chance to sell grief that had become unbearable. The chance to purchase a few hours of someone else’s uncomplicated joy and hold it in your head like a warm stone. The demand was not for luxury. It was for the same reason people have always reached for whatever substance or practice promises to make the inside of their skull a less difficult place to inhabit.

The pharmaceutical companies watching this black market were not horrified. They were taking notes.

Legitimization and the Memory Standard

The watershed moment came in 1987, when the United States Congress passed the Neural Commerce Regulation Act — the first piece of legislation anywhere in the world to formally acknowledge that memory was a transferable commodity and to establish a legal framework for its trade. The debate leading up to the NCRA was long, contentious, and occasionally surreal, featuring testimony from neuroscientists, ethicists, veterans’ advocacy groups, and at least one sitting senator who had quietly purchased black-market memories and was therefore arguing from a position of personal experience he was careful not to disclose.

The NCRA legalized memory extraction and transfer under licensed clinical conditions. It established the Memory Commerce Administration to oversee safety standards. It created a classification system — Tier One memories (sensory experiences, skills, benign emotional states) could be freely traded; Tier Two (significant emotional content, identity-adjacent memories) required additional consent documentation; Tier Three (severe trauma, memories involving third parties) were subject to restricted protocols that, in practice, the industry spent the following decade methodically lobbying to loosen.

Within five years of legalization, there were Memory Clinics in every major American city. Within ten, they were in strip malls. The aesthetic evolved quickly from the clinical to the aspirational: soft lighting, carefully chosen music, consultants who called themselves Memory Advisors and wore the particular expression of someone trained to project both competence and warmth simultaneously. The brochures used words like clarity and renewal and the you that you were always meant to be.

The class dynamics clarified early and have never really shifted. Selling memories is, on Memory Market Earth, what it has always been: something people do when they need money. The robust market for traumatic memory — purchased by research institutions, by certain therapeutic programs, by a murkier category of private buyers whose motivations the MCA’s oversight division has investigated several times without conclusive result — means that people in economic distress have a ready, if deeply personal, resource to liquidate. This is spoken of, in polite company, as empowering. The people doing the selling tend to describe it differently, in the years that follow, though many of them find the years that follow harder to describe than they expected.

The wealthy, meanwhile, buy. Courage is the perennial bestseller — specifically, the distilled experiential memory of physical bravery, sourced from soldiers and first responders and athletes, processed and standardized and available in three dosage strengths. Languages can be partially acquired through skill memories, though the results are imperfect and the fluency tends to degrade without reinforcement. The memory of falling in love — the early, uncomplicated part, before the complications arrive — retails for more than most people on Memory Market Earth make in a month, and the waiting lists at the premium clinics run to years.

What Gets Lost in the Transfer

Here is what the brochures, in their careful language, do not say.

Memory is not a file. This is the thing the early researchers understood imperfectly and the industry has understood perfectly and chosen to discuss only in the fine print. A memory is not a discrete object that can be removed from one place and inserted into another without consequence to either location. It is a node in a network. It is connected, by threads both obvious and invisible, to everything else you have ever experienced, felt, or understood about yourself. When you remove it, you do not simply create an absence. You create a reconfiguration. The network reorganizes around the gap. And the reorganized network is, in ways that are measurable and documented and carefully not advertised, a different network than the one that existed before.

The clinical term is Mnemonic Restructuring Syndrome. The colloquial term, used on Memory Market Earth in the same half-joking, half-serious way that people on our Earth might use the word “burnout,” is going flat. The people it happens to don’t always notice at first. They notice the absence of the pain they sold, which is real and welcome. What they don’t notice, initially, is the corresponding absence of whatever the pain was teaching them. The capacity for a particular kind of empathy that only develops through having suffered a specific thing. The resilience that is not an absence of difficulty but a relationship with it, built through having survived something and knowing, in your bones, that you survived it. The part of your identity that was forged in the experience you just sold for three months’ rent.

The therapy practices that have grown up around this phenomenon are, on Memory Market Earth, one of the fastest growing sectors of the healthcare industry. There is a particular irony in this that the culture has largely chosen not to examine directly: the Memory Clinics create, in a meaningful percentage of their clients, a condition that requires ongoing therapeutic intervention, and the same parent companies that own the Memory Clinics have made significant investments in the therapy practices that treat Mnemonic Restructuring Syndrome. The regulators have noted the conflict of interest. The lobbying in response has been substantial.

The Synthetic Turn

It took the industry less time than anyone should have been comfortable with to realize that the human supplier was an inefficiency.

The early memory trade depended on willing sellers — people who had something worth extracting and needed the money badly enough to extract it. This created supply chain problems. Trauma, it turned out, was abundant but inconsistent. Two people could live through nearly identical experiences and produce memories with wildly different market values, depending on factors that resisted standardization: temperament, context, the specific neurological signature of the individual doing the suffering. Courage memories sourced from combat veterans varied enough in quality that premium buyers complained. The Memory Commerce Administration’s Tier classifications created compliance costs. Human suppliers had lawyers, occasionally, and feelings about the process, more frequently.

The solution arrived in 2003, when a joint research team at a Zurich laboratory published findings suggesting that synthetic memory compounds — chemically constructed experiential analogs built from the aggregate data of thousands of organic memory extractions — were, in double-blind trials, functionally indistinguishable from the organic product in approximately 78% of recipients. The remaining 22% reported a quality they struggled to articulate. They used words like thin and painted and, most commonly, like remembering something from a movie I watched a long time ago. The research team noted this in their findings. The pharmaceutical companies reviewing the findings noted the 78%.

Synthetic memories hit the consumer market in 2007 and restructured it within a decade. The price of courage dropped by sixty percent. Synthetic joy — a standardized emotional experience built from composite organic sources, smooth and consistent in the way that no actual human joy ever quite manages to be — became available over the counter in several European markets by 2011. The organic memory trade didn’t disappear; it stratified. Authentic human-sourced memories became a premium product, marketed with the same language the food industry uses for anything it wants to charge more for. Single-origin. Small-batch. Unblended. The people who could afford them bought them on the grounds that something real, however imperfect, was worth more than something manufactured to specification. The people who couldn’t afford them bought synthetic and told themselves the difference probably didn’t matter.

The 22% kept using the word thin. The industry funded three studies suggesting that word was a placebo effect. Two of the three studies were conducted by researchers with financial ties to the synthetic memory sector, which the fine print disclosed and nobody read.

What the synthetic turn introduced, beyond the economics, was a new category of person: someone whose internal landscape had been substantially constructed from experiences that had never happened to anyone, assembled in a laboratory from statistical composites of other people’s lives. They functioned. They felt, subjectively, like themselves. But the self they felt like was, in a meaningful sense, a product. Designed, tested, and optimized for consumer satisfaction in ways that actual human experience, with its chaos and specificity and insistence on leaving marks, stubbornly refuses to be.

The Question of Who You Are

The philosophical debate that Memory Market Earth cannot resolve — that it argues about in academic journals and late-night talk shows and dinner tables and the quiet aftermath of Memory Clinic appointments — is the Ship of Theseus problem, made biological and personal and urgent.

If you sell the memories of your difficult childhood and purchase the memory of someone else’s stable and loving one, are you the same person? The law says yes, because the law needs a continuous legal identity to function and is not in the business of existential nuance. The Memory Commerce Administration says yes, because its mandate is to regulate the trade, not to question it. The philosophers say it depends on your theory of personal identity, which is not helpful when you are sitting in a consultation room being asked to sign the consent forms.

The people who have done it — sold significant portions of their experiential history and rebuilt themselves from a combination of what remained and what they purchased — describe it in ways that cluster around a particular image. They say it is like living in a house where some of the rooms have been renovated. The new rooms are nicer. They are cleaner and more comfortable and do not have the particular draft that used to come in under the door. But they do not feel, quite, like your rooms. You know, in some way that precedes language, that you did not grow up in them. And the rooms you did grow up in, the ones that were renovated away, are gone in a way that is different from forgetting. Forgetting leaves a ghost. This leaves a clean wall where the door used to be.

The people who have bought memories to supplement what they have — purchased courage, or joy, or the warm weight of someone else’s uncomplicated love — describe something adjacent but different. The memories function. They feel real in the moment of recall. But they do not connect the way native memories connect. They sit in the network like well-made furniture in a house they were not designed for. Comfortable, maybe. But not quite right. And over time, the distance between the purchased self and the native self — the gap between who you bought yourself to be and who the underlying architecture of your experience actually made you — becomes a thing that requires maintenance. Regular sessions. Reinforcement doses. A subscription, effectively, to an ongoing process of being someone that you have to keep paying to remain.

The Verdict Nobody Will Render

Memory Market Earth is not a dystopia in the cinematic sense. Nobody is being dragged to the clinics. The lines are long because people are choosing to stand in them, and they are choosing to stand in them because the thing being offered — relief, enhancement, the chance to be less haunted or more capable — is genuinely, honestly appealing. The technology works. The pain relief is real. The courage purchased by the man who was afraid of everything and is now merely cautious is not fake courage; it functions in the world and produces real outcomes and his life is, by most measurable standards, better.

The loss is harder to measure. It happens slowly, in the space between who someone was becoming and who they decided to purchase instead. It lives in the therapy offices and the late-night conversations and the quiet realization, arriving sometimes years after the procedure, that the thing that was supposed to make you more yourself has made you, in some fundamental way, less legible to yourself. That the version of you who struggled through the hard thing, who came out the other side changed and scarred and permanently altered, was building something that the clean, unburdened version of you does not have and cannot buy.

The Mettler Institute — the foundation that bears Eliane Mettler’s name, funded by the industry her research created, deeply conflicted about its own legacy — has a phrase they use in their public communications: the freedom to choose your own story. It is a good phrase. It contains something true.

What it leaves out is that some of the most important chapters of a story are the ones that hurt. And that a story with all the difficult parts sold off is, in the end, a story that is very easy to read and very hard to believe in.

Join me tomorrow for N — and another world waiting just beyond the edge of what we know.